MSU drug developers secure seed funding for cancer and TB drug development
Two Michigan State University biomedical researchers have received a total of $600,000 in high-risk, high-reward Catalyst grants from the Dr. Ralph and Marian Falk Medical Research Trust. Karen Liby, professor in the Department of Pharmacology and Toxicology — a shared department of the Colleges of Osteopathic Medicine and Human Medicine — and Robert Abramovich, associate …
MSU drug developers secure seed funding for cancer and TB drug development Read More »